Ignite Creation Date:
2024-05-06 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03466073
Status:
COMPLETED
Last Update Posted:
2020-01-27
First Post:
2018-03-02
Brief Title:
A Phase 1b2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
Sponsor:
BioAegis Therapeutics Inc
Organization:
BioAegis Therapeutics Inc